GGrantIndex
Sort

21,453 grants matching tuberculosis

Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis

$1,368,144
Shabaana A. Khader · University Of Chicago · R01 · FY2024 · AI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM

$1,367,841
University Of Hawaii At Manoa · U01 · FY2002 · AI

RP4: Harnessing autophagy to treat tuberculosis

$1,367,677
Michael Shiloh · Ut Southwestern Medical Center · U19 · FY2019 · AI

An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples

$1,364,708
Timothy Charles Rodwell · University Of California, San Diego · R01 · FY2014 · AI

MACROPHAGES, DENDRITIC CELLS AND PATHOGENS

$1,364,588
Carl F Nathan · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · AI

San Francisco Bay Clinical Trials Unit

$1,364,094
Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2015 · AI

THE ANOPHELES GAMBIAE GENOME PROJECT

$1,363,735
University Of Notre Dame · U01 · FY2002 · AI

Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis

$1,363,070
Shabaana A. Khader · Washington University · R01 · FY2022 · AI

T cell recognition of the MR1 presented microbial metabolome

$1,362,106
Erin June Adams · University Of Chicago · R01 · FY2020 · AI

Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda

$1,361,742
Charles Martyn Bark · Case Western Reserve University · R01 · FY2022 · AI

Advancing a new TB drug through early clinical trials

$1,361,370
Sequella, Inc. · UC1 · FY2004 · AI

TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT, ILLINOIS OUTSIDE O

$1,360,561
Matthew A Roberts · Illinois State Dept Of Public Health · U52 · FY2013 · PS

The Ohio State University AIDS Clinical Trials Unit

$1,359,474
Susan L Koletar · Ohio State University · U01 · FY2009 · AI

DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial

$1,357,160
Payam Nahid · University Of California, San Francisco · U01 · FY2021 · AI

TUBERCULOSIS CONTROL PROGRAM AND AIDS

$1,357,095
Jim Scioneaux · Louisiana State Department Of Health · U52 · FY2006 · PS

Disseminated Tuberculosis in HIV Infection

$1,356,004
Dartmouth College · U01 · FY2005 · AI

VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT

$1,355,530
Vanderbilt University · U01 · FY2003 · AI

RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection

$1,355,032
Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2022 · AI

FISH-Flow platform for host-based tuberculosis diagnostics

$1,354,623
Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2013 · AI

Task A81: Anti-mycobacterial Evaluation of Chemical Entities in Mouse Models

$1,353,907
Anne Lenaerts · Colorado State University · N01 · FY2016 · AI

DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial

$1,350,629
Payam Nahid · University Of California, San Francisco · U01 · FY2023 · AI

Genetic and metabolic determinants of multiple drug resistance in tuberculosis

$1,349,629
Megan B Murray · Brigham And Women'S Hospital · U19 · FY2011 · AI

Inhaled Large Porous Particles for Treatment of MDR-TB

$1,347,814
David A Edwards · Harvard University · U01 · FY2006 · AI

San Francisco Bay Clinical Trials Unit (CTU)

$1,347,336
Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2021 · AI

T cell recognition of the MR1 presented microbial metabolome

$1,346,843
Erin June Adams · University Of Chicago · R01 · FY2021 · AI